Hizentra Patient Record Printable

Hizentra Patient Record Printable Start and stop time of infusion and assessment of patient tolerability should be documented in appropriate flow chart or clinical record electronic or paper Document vital signs as required in the appropriate flow chart or clinical record electronic or paper Provide patient notification of transfusion documentation where required

Simply call 1 877 355 4447 Mon Fri 8 AM 8 PM ET to get started Hizentra Connect has several assistance programs that may be able to help you find coverage pay for out of pocket expenses for Hizentra stay on therapy in the event of a lapse in coverage and even get a free 1 month supply of Hizentra Hizentra 200 mg ml solution for subcutaneous injection Human normal immunoglobulin SCIg Subcutaneous Immunoglobulin Read all of this leaflet carefully before you start using this medicine because it contains important information for you Keep this leaflet You may need to read it again

Hizentra Subcutaneous Immunoglobulin Human Page 1 of 62 PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION Hizentra Subcutaneous Immunoglobulin Human 20 Solution for injection 200 mg mL Pharmacopeial Passive Immunizing Agent CSL Behring Canada Inc 55 Metcalfe Street

Pre-crafted templates use a time-saving solution for producing a varied series of files and files. These pre-designed formats and layouts can be made use of for numerous personal and expert tasks, consisting of resumes, invites, leaflets, newsletters, reports, presentations, and more, streamlining the content development process.

Hizentra Patient Record Printable

FAQs Hizentra

PI Dosing And Administration HIZENTRA Immune Globulin Subcutaneous

Co pay Assistance HIZENTRA Immune Globulin Subcutaneous Human 20

FAQs Hizentra

Frequently Asked Questions HIZENTRA Immune Globulin Subcutaneous

Hizentra Patient Infusion Diary By PharmiWeb2002 Limited

Patient Resources For Starting Hizentra

https://www.hizentra.com/hcp/patient-resources
With proper training your patients can learn how to administer Hizentra on their own See how easy self administration can be for patients and review dosing and administration options We also have resources to download and step by step videos to help patients self infuse Hizentra

Hizentra Downloads CSL Behring PLUS Ordering Portal

https://cslbehringplus.rxdirect.ca/pages/resource-centre
My Hizentra Patient Binder A resource binder to help you make the most out of your therapy including tools to track your treatment a Step by Step Self Administration Guide information about Hizentra and more My Hizentra Therapy Log Sheets

My Hizentra Name Subcutaneous Immunoglobulin Human 20

https://patients.cslbehring.ca//documents/hizentra/logsheet_…
Hizentra Waste Report Record any wasted broken contaminated or expired vials pre filled syringes in the table below Follow your healthcare professional or blood bank pharmacy instructions on product wastage If the vial pre filled syringe has a manufacturer s defect broken seal particles or cloudy solution record below and return

Manual Push Quick View Infusion Mat Patient Resource Binder

https://hcp.cslbehring.ca//documents/hizentra/hizentra-infusi…
1 Record treatment 2 Clean up STEP 4 Record Clean Tell your healthcare provider about any problems you have during your infusions Always follow the advice of your healthcare team Once you have received training from your healthcare provider to self administer Hizentra use this mat to help prepare for your infusion For more

Step by step Instructions For Self administering Hizentra

https://www.hizentra.com/common/pdf/Patient-kit-infusion-guid…
Hizentra is a prescription medicine used to treat Primary immune deficiency PI in patients 2 years and older Chronic inflammatory demyelinating polyneuropathy CIDP in adults Treatment with Hizentra might not be possible if your doctor determines you have hyperprolinemia too much

The Hizentra app your infusion log is never farther away than your phone Stay on track with your therapy and keep a clear record of your infusion history to help manage your treatment needs Hizentra Subcutaneous Immune Globulin Human SCIG is indicated for The treatment of patients with Primary Immune Deficiency PID and Secondary Immune Deficiency SID who require immune globulin replacement therapy The treatment of patients with Chronic Inflammatory Demyelinating Polyneuropathy

Option 1 Press 1 for EN and 2 for FR Option 2 Press 3 for Healthcare Professional To reach the program via email hizentra care innomar strategies PLEASE FAX COMPLETED FORM TO 1 888 490 4106 Program Services Patient Information Required Reimbursement Product and Supplies Innomar Nurse Training Training Notes Patient